Quantcast
Channel: MassDevice
Viewing all articles
Browse latest Browse all 1713

Trovagene raises $7m for precision cancer therapies

$
0
0

TrovageneTrovagene (NSDQ:TROV) said today that it inked a deal with unnamed investors to sell approximately $7.1 million of its common stock.

According to the deal, Trovagene plans to sell 6,191,500 shares of common stock. In a concurrent private placement, the biotech said it will issue warrants to buy up to 4,643,626 shares of common stock.

Get the full story at our sister site, Drug Delivery Business News.

The post Trovagene raises $7m for precision cancer therapies appeared first on MassDevice.


Viewing all articles
Browse latest Browse all 1713

Trending Articles